AQST
Aquestive Therapeutics Inc
NASDAQ: AQST · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$4.10
+1.23% today
Updated 2026-04-30
Market cap
$497.94M
P/E ratio
—
P/S ratio
11.18x
EPS (TTM)
$-0.78
Dividend yield
—
52W range
$2 – $8
Volume
1.7M
Aquestive Therapeutics Inc (AQST) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-65.4%
Last 4 quarters
Revenue YoY growth
+9.7%
Most recent quarter
EPS YoY growth
-61.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+2.1%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+3.4%
2026-03-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-04 | $-0.26 | -100.0% | $4.12 | $4.26 | +3.4% |
| 2025-11-05 | $-0.14 | +0.0% | $6.08 | $6.13 | +0.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.13 | $-0.26 | -100.0% | $13.02M | +9.7% |
| 2025-09-30 | $-0.14 | $-0.14 | +0.0% | $12.81M | -5.4% |
| 2025-06-30 | $-0.17 | $-0.14 | +17.6% | $10.00M | -50.2% |
| 2025-03-31 | $-0.08 | $-0.22 | -179.4% | $8.72M | -27.7% |
| 2024-12-31 | $-0.13 | $-0.16 | -21.3% | $11.87M | -10.1% |
| 2024-09-30 | $-0.13 | $-0.13 | +0.0% | $13.54M | +4.2% |
| 2024-06-30 | $-0.12 | $-0.03 | +75.0% | $20.10M | +51.8% |
| 2024-03-31 | $-0.08 | $-0.17 | -112.5% | $12.05M | — |
| 2023-12-31 | $-0.08 | $-0.11 | -37.5% | $13.21M | — |
| 2023-09-30 | $-0.11 | $-0.03 | +72.7% | $13.00M | — |
| 2023-06-30 | $-0.12 | $-0.10 | +16.7% | $13.24M | — |
Frequently asked questions
Has Aquestive Therapeutics Inc beaten earnings estimates?
Aquestive Therapeutics Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -65.4% over the last 4 quarters.
How does AQST stock react to earnings?
AQST stock has moved an average of +2.1% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Aquestive Therapeutics Inc's revenue growth rate?
Aquestive Therapeutics Inc reported year-over-year revenue growth of +9.7% in its most recent quarter, with EPS growing -61.8% year-over-year.